Table 2.
Multivariate linear regression analyses for EQ-5D-5l utility score (transformed) and EQ-VAS.
| EQ-5D utility scores (transformed) | EQ VAS | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3–6 months | 7–9 months | 10–12 months | 13–18 months | 19–24 months | >24 months | 3–6 months | 7–9 months | 10–12 months | 13–18 months | 19–24 months | >24 months | |
| n = 1,672 | n = 1,183 | n = 1,333 | n = 2,745 | n = 2,574 | n = 517 | n = 1,672 | n = 1,183 | n = 1,333 | n = 2,745 | n = 2,574 | n = 517 | |
| Age | ||||||||||||
| 18–24 years | −7.732* | −5.989 | −2.486 | −10.607* | 2.522 | −1.462 | −2.490 | −1.256 | −4.841* | −8.287* | −5.516 | |
| 25–34 years | −5.621* | −6.305* | −4.010* | −5.538* | −6.052 | −2.785* | −3.903* | 0.206 | −3.155* | −2.769* | −0.386 | |
| 35–44 years | −1.993 | −6.511* | −1.650 | −3.256* | −1.183 | −1.381 | −3.059* | −0.433 | −1.407 | −1.403 | 1.046 | |
| 45–54 years (ref) | ||||||||||||
| 55–64 years | 1.382 | −2.960 | 0.151 | 1.022 | 4.844 | 1.431 | 0.044 | 2.757* | 0.609 | 1.912* | 5.064* | |
| 65–88 years | 5.918 | 9.759* | 11.055* | 8.716* | 15.802* | 2.707 | 11.739* | 5.650* | 5.098* | 8.859* | 8.889* | |
| Gender | ||||||||||||
| Male | 5.094* | 5.595* | 5.117* | 3.826* | 6.364* | 2.919* | 1.808 | 1.583 | 1.627 | 3.324* | ||
| Female (ref) | ||||||||||||
| Level of education | ||||||||||||
| Low | −1.209 | −5.074* | −7.791* | −7.108* | −6.542* | −7.685* | 0.465 | −3.700* | ||||
| Middle | −3.481* | −5.147* | −3.825* | −2.426* | −2.468* | −2.837 | −1.600 | −2.666* | ||||
| High (ref) | ||||||||||||
| Married/living with significant other | ||||||||||||
| Yes (ref) | ||||||||||||
| No | −1.778 | −3.137 | −1.161 | −2.513* | −1.382 | −1.312 | −1.734* | |||||
| Occupational status before COVID-19 | ||||||||||||
| Paid work (ref) | ||||||||||||
| No paid work | −9.522* | −6.556* | −9.878* | −9.879* | −5.129* | −8.196* | −3.266* | |||||
| Comorbidity | ||||||||||||
| Yes | −5.406* | −5.713* | −5.609* | −6.460* | −7.971* | −9.203* | −3.805* | −2.632* | −4.058* | −3.713* | −4.802* | −5.192* |
| No (ref) | ||||||||||||
| Overweight | ||||||||||||
| Yes (ref) | ||||||||||||
| No | 0.636 | 3.867* | 7.638* | 2.169* | 4.211* | |||||||
| Hospital admission | ||||||||||||
| Yes | −2.225 | 5.454* | 5.604 | |||||||||
| No (ref) | ||||||||||||
| Vaccinated | ||||||||||||
| Yes (ref) | ||||||||||||
| No | −6.379* | −7.671* | −2.734 | −5.764* | −5.352* | −2.505 | −5.388* | |||||
This table shows the results of the multivariate linear regression analyses, presented separately for respondents at different time periods since acute infection. Respondents with missing data on gender, level of education, household situation (married/living with significant other), or BMI, were excluded from the regression analyses (n = 170; 1.7%). EQ-5D utility scores were transformed to a 0–100 scale.
Statistically significant determinants (p < 0.05).